Alegre Pharmaceuticals Private Limited
About Alegre Pharmaceuticals Private Limited
Data last updated:
Alegre Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC323325. Its GSTIN is 07AAQCA0064K1ZJ (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ramakant Jain and Jolly Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2603 Ground Floor Chatta Pratap Singh Kinari Bazaar Chandni Chowk, Delhi, India – 110006.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.98 Lakh, a growth of 63% compared to the previous year. For the same year it recorded a net loss of ₹32,769 (net margin -2.1%) and EBITDA of ₹12,751 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Alegre Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2603 Ground Floor Chatta Pratap Singh Kinari Bazaar Chandni Chowk, Delhi, India – 110006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alegre Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alegre Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Alegre Pharmaceuticals Private Limited, buy the company report.
Financials of Alegre Pharmaceuticals Private Limited
FY 2025 filings availableAlegre Pharmaceuticals Private Limited reported revenue of ₹15.98 Lakh (up 63% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over three years, including 63% growth in the latest year. EBITDA fell 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12,751 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹32,769 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | -2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alegre Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alegre Pharmaceuticals Private Limited
Alegre Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramakant Jain | Director | 06 Sep 2017 | 9 Years 1 Months | Current |
| Jolly Jain | Director | 06 Sep 2017 | 9 Years 1 Months | Current |
| Shashi Kant Jain | Director | 06 Sep 2017 | 9 Years 1 Months | Current |
Auditor
Alegre Pharmaceuticals Private Limited is audited by VNGS AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VNGS AND ASSOCIATES | FY 2023 | 028684N |
Shareholding
The shareholding of Alegre Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Alegre Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alegre Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alegre Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alegre Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAQCA0064K1ZJ | Delhi | Active | 08 Jan 2021 |
To see the full GST registrations and return filing status of Alegre Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alegre Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Jolly Jain was appointed as Director on 06 Sep 2017.
Frequently asked questions
Alegre Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 September 2017 (9+ years old) and is registered under CIN U51909DL2017PTC323325.
Alegre Pharmaceuticals has 3 current directors:
- Ramakant Jain - Director
- Jolly Jain - Director
- Shashi Kant Jain - Director
The latest financial statements of Alegre Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Alegre Pharmaceuticals is 07AAQCA0064K1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Alegre Pharmaceuticals is U51909DL2017PTC323325. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alegre Pharmaceuticals was incorporated on 06 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Jolly Jain was appointed as Director on 06 Sep 2017. Ramakant Jain was appointed as Director on 06 Sep 2017. Shashi Kant Jain was appointed as Director on 06 Sep 2017.
The registered office of Alegre Pharmaceuticals is at 2603 Ground Floor Chatta Pratap Singh Kinari Bazaar Chandni Chowk, Delhi, India – 110006.
Alegre Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Alegre Pharmaceuticals is compliant as of 04 August 2026. The company is actively filing with the Registrar of Companies.